NICE Updates Guidance On Kisqali For Advanced Breast Cancer
Three months ago, the National Institute of Health and Care Excellence (NICE) issued guidance rejecting the use of Kisqali (ribociclib) for ... Read More
Could AI Disrupt Big Pharma?
Artificial intelligence (AI) and machine learning are both areas that have been growing and ones that are expected to change the ... Read More
New Subscription Payment Model To Be Trialled For Pharma
NHS England, NHS Improvement and the National Institute for Health and Care Excellence (NICE) will be leading a new trial to ... Read More
NHS Announces Medicines Safety Improvement Programme
The NHS published its new Patient Safety Strategy earlier this week, which included plans to develop a Medicines Safety Improvement Programme ... Read More
Pharmaceutical Industry Continues Significant Investment In R&D
Research and development (R&D) investment by the pharmaceutical industry in the UK continues apace, new figures show, with £377.3 million spent ... Read More
‘Game-Changing’ Cancer Drugs To Be Fast-Tracked By NHS
The NHS has announced that patients could soon be given access to what are described as “game-changing” cancer drugs through a ... Read More
Research Finds ‘Hundreds Of Medical Procedures’ To Be Ineffective
When a pharmaceutical company that uses tertiary packaging services has a drug that is widely used for treatment of a condition, ... Read More
US States Tackle Big Pharma Over ‘Opioid Crisis’
It’s an interesting time for big pharma companies over in the US, and it’s a time that everyone from lawmakers to ... Read More
Brexit: Will US Firms Be Able To Bid For NHS Contracts?
The US ambassador to the UK, Woody Johnson, has sparked concerns that the entire British economy could be up for grabs ... Read More